Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Follow-up of Saudi children vaccinated with Haemophilus influenzae type B vaccine.

Khalil M, Al-Mazrou Y, Al-Howasi M, Al-Jeffri M, Al-Ghamdy Y.

Ann Saudi Med. 2000 Mar;20(2):122-4.

PMID:
17322707
2.
3.

Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.

Tejedor JC, Moro M, Merino JM, Gómez-Campderá JA, García-del-Rio M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Ruiz-Contreras J, Martin-Ancel A, Roca J, Boceta R, García-Corbeira P, Maechler G, Boutriau D; Spanish 102547 Study Group.

Pediatr Infect Dis J. 2008 Jul;27(7):579-88. doi: 10.1097/INF.0b013e31816b4561.

PMID:
18536619
4.

Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants.

Hadida M, Cuevas LE, Moghadami A, Baccoosh M, Gurgel RQ, Hart CA.

Trop Med Int Health. 1998 Feb;3(2):95-9.

5.
6.

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.

Olivier C, Belohradsky BH, Stojanov S, Bonnet E, Petersen G, Liese JG.

Vaccine. 2008 Jun 13;26(25):3142-52. doi: 10.1016/j.vaccine.2007.11.096. Epub 2008 May 6.

PMID:
18502545
7.

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.

Pace D, Snape M, Westcar S, Oluwalana C, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, Pollard AJ.

Arch Dis Child. 2008 Nov;93(11):963-70. doi: 10.1136/adc.2007.136036. Epub 2008 May 7.

PMID:
18463125
8.

Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.

Omeñaca F, Garcia-Sicilia J, Boceta R, Sistiaga-Hernando A, García-Corbeira P.

Pediatr Infect Dis J. 2007 Sep;26(9):824-9.

PMID:
17721379
9.

Immunogenicity study of Haemophilus influenzae type B conjugate vaccine in Indian infants.

Phadke MA, Kulkarni MV, Sovani VB, Lokeshwar MR, Venkataraman R.

Indian Pediatr. 1997 Sep;34(9):779-83.

PMID:
9492415
10.

Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.

Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E.

Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):282-94.

PMID:
19323013
11.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
12.

Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.

Clin Infect Dis. 2008 Jan 15;46(2):186-92. doi: 10.1086/524668.

13.

Anticapsular polysaccharide IgG concentrations in Mexican children formerly immunized with Haemophilus influenzae b PRP-T vaccine.

de León PG, Díaz García FJ, Arredondo JL, Segura J, Cerezo SG, Santos JI.

Hum Vaccin. 2007 Sep-Oct;3(5):187-91. Epub 2007 May 2.

PMID:
17643076
14.
15.

Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):1008-9.

16.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

17.
18.

Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults.

Dentinger CM, Hennessy TW, Bulkow LR, Reasonover AL, Romero-Steiner S, Holder PF, de Leon PG, Carlone GM, Parks DJ, Parkinson AJ, Singleton RJ, Levine OS, Butler JC.

Hum Vaccin. 2006 Jan-Feb;2(1):24-8. Epub 2006 Jan 18.

PMID:
17012896
19.

A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.

Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, Lefevre I.

Hum Vaccin. 2008 Jan-Feb;4(1):60-6. Epub 2007 Sep 23.

PMID:
18376148
20.
Items per page

Supplemental Content

Write to the Help Desk